comprehensive
Previous article:
New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article: After Sarepta trial failure, Duchenne families brace for more debate
Next article: After Sarepta trial failure, Duchenne families brace for more debate
focus
focus
-
A biotech analyst on neuroscience, placebo effect, not over
2025-10-01 13:30 -
The best solution to the drug shortages problem
2025-10-01 13:28 -
Why failed clinical trials don’t always spell doom for a new drug
2025-10-01 13:27 -
Friends ask where James Watson's attitudes about race came from
2025-10-01 12:11 -
Coloradans with cystic fibrosis could lose access to Trikafta
2025-10-01 11:50 -
American woman, child freed after being kidnapped in Haiti last month
2025-10-01 11:35